Investigation of the effectiveness of an upper limb functional training program using Virtual Reality technology for patients with Parkinson's disease

Investigation of the effectiveness of an upper limb functional training program using Virtual Reality technology for patients with Parkinson's disease - Efficacy of Virtual Reality for the Upper Extremity in Patients with Parkinson's Disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000058325

Enrollment

Registered

2025-06-30

Start date

2025-06-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

Intervention period is 8 weeks.Frequency of intervention is twice a week.Training time is 60 minutes per session.Forty minutes will be used for regular practice, by 20 minutes of Virtual Reality inter

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Able to come to outpatient rehabilitation twice a week for one hour per visit. Those whose Hoehn-Yahr severity classification is Stage III or lower Persons who have given written consent to participate in this study

Exclusion criteria

Exclusion criteria: above the cut-off value in the screening for Virtual Reality sickness. inner ear disorders who are prone to Virtual Reality sickness Those who have difficulty continuing to use VR for more than 10 minutes due to Virtual Reality sickness during the Virtual Reality experience conducted beforehand. Patients receiving Levodopa-carbidopa intestinal gel therapy or Deep Brain Stimulation vision impairment significant enough to affect the intervention diagnosed with other neurological diseases or dementia. Persons with limited range of motion of the upper limb that makes it difficult to perform Virtual Reality. Other persons deemed unfit by the physician.

Design outcomes

Primary

Measure	Time frame
Box and Block Test Evaluations will be conducted at the beginning of the study, 2 months after the start of the study, and 5 months after the start of the study	—

Secondary

Measure	Time frame
Basic Information Age,gender,name of primary disease,and dose of antiparkinsonism medication Physical and cognitive function assessment Disease severity:Hoehn-Yahr Stage Cognitive Function Test Assessment:The Montreal Cognitive Assessment Japanese version Unified Parkinson's Disease Rating Scale Upper Limb Functional Assessment:Nine hole peg Test Depression Assessment:Geriatric depression Scale15 Balanced Evaluation:The Mini-Balance Evaluation Systems Test Grip strength Measurement of muscle mass using the Inbody body Effectiveness determination in goal-setting:Goal Attainment Scale	—

Measure

Time frame

Basic Information Age,gender,name of primary disease,and dose of antiparkinsonism medication Physical and cognitive function assessment Disease severity:Hoehn-Yahr Stage Cognitive Function Test Assessment:The Montreal Cognitive Assessment Japanese version Unified Parkinson's Disease Rating Scale Upper Limb Functional Assessment:Nine hole peg Test Depression Assessment:Geriatric depression Scale15 Balanced Evaluation:The Mini-Balance Evaluation Systems Test Grip strength Measurement of muscle mass using the Inbody body Effectiveness determination in goal-setting:Goal Attainment Scale

—

Countries

Japan

Contacts

Public ContactKodai Yamaguchi

Nagasaki Kita Hospital Deparetment of Rehabilitation

y.m.g.ch.ko@gmail.com+81-866-8700

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Investigation of the effectiveness of an upper limb functional training program using Virtual Reality technology for patients with Parkinson&#39;s disease